Intarcia raises $225m to fund diabetes trial | Medtech funding for the week of April 27, 2015

Here's a look at some of the top legal news stories for medical device companies this week: Intarcia adds $225m for Type II diabetes trial; Gynesonics raises $3m for VizAblate fibroid device; Lombard Medical takes out $26m loan for Aorfix stent graft; Alliqua prices $30m offering; Contego Medical raises $6m for embolic filter tech

Intarcia adds $225m for Type II diabetes trial

April 28, 2015 by Brad Perriello

Contego Medical, Gynesonics, Hatteras Venture Partners, Intarcia Therapeutics, Lombard Medical Technologies, Lookout Capital, Medical Mutual, Mountain Group Partners, Oxford Finance, Alliqua Biomedical

News Well, Funding Roundup

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1c2wbtd